Prices are updated after-hours


Sort by: after hours percent change | delayed percent change | gain open | gain high | gain close | publishing date

tags : Als    save search

Todays' Top-5
NeuroSense Therapeutics Reports Positive Results from Stage III ALS Biomarker Study
Published: 2022-06-27 (Crawled : 13:00) - biospace.com/
NRSN | News | $2.5 47.06% 0.0% | twitter stocktwits trandingview |
| | O: 54.76% H: 26.92% C: -3.85%

als therapeutics positive results
Sally Frykman, CMO von Velodyne Lidar, wurde als Finalistin für den Sensors Converge Award nominiert
Published: 2022-06-11 (Crawled : 17:00) - velodynelidar.com
VLDR S | $1.125 -8.54% 0.81% | twitter stocktwits trandingview |
Electronic Technology
| Email alert Add to watchlist
FNCTF | News | $11.38 | twitter stocktwits trandingview |
Communications
| Email alert Add to watchlist

cmo als
Cytokinetics Announces Start of Open-Label Extension Study for Patients Completing COURAGE-ALSManaged Access Program for People Who Have Completed Prior Cytokinetics ALS Trials to Begin in 2H 2022
Published: 2022-06-16 (Crawled : 14:00) - biospace.com/
CYTK | $48.93 3.56% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: -2.48% H: 0.0% C: 0.0%

trials for extension als program
Amylyx Pharmaceuticals Announces Health Canada Approval of ALBRIOZA™ for the Treatment of ALS
Published: 2022-06-13 (Crawled : 12:00) - biospace.com/
AMLX | $19.94 6.57% 4.97% | twitter stocktwits trandingview |
| | O: -3.25% H: 15.66% C: -0.69%

treatment for canada health als approval
Stealth BioTherapeutics Presents New SBT-272 Data Demonstrating Improvement in Upper Motor Neuron Function in ALS Disease Model at Keystone Neurodegeneration Symposium
Published: 2022-06-08 (Crawled : 12:00) - biospace.com/
MITO | News | $0.2674 -4.16% 0.36% | twitter stocktwits trandingview |
Health Technology
| | O: 58.35% H: 11.2% C: -14.06%

sbt-272 disease als symposium
Amylyx Pharmaceuticals Receives Notification of PDUFA Date Extension for AMX0035 for the Treatment of ALS
Published: 2022-06-03 (Crawled : 12:20) - biospace.com/
AMLX | $19.94 6.57% 4.97% | twitter stocktwits trandingview |
| | O: 36.13% H: 4.81% C: -7.14%

amx0035 treatment pdufa for als
NeuroSense Enrolls First Patient in Phase IIb ALS Trial for its Combination Therapy PrimeC
Published: 2022-06-01 (Crawled : 13:00) - biospace.com/
NRSN | News | $2.5 47.06% 0.0% | twitter stocktwits trandingview |
| | O: 8.48% H: 1.33% C: -8.47%

primec for als trial therapy
Amylyx Pharmaceuticals Announces Presentation of New Analysis of CENTAUR Trial Results at the European Network to Cure ALS 2022 Meeting
Published: 2022-05-26 (Crawled : 17:00) - biospace.com/
AMLX | $19.94 6.57% 4.97% | twitter stocktwits trandingview |
| | O: -0.58% H: 0.0% C: -7.98%

als trial presentation results
NeuroSense Therapeutics to Present at the ALS Drug Development Summit in Boston on May 26, 2022
Published: 2022-05-23 (Crawled : 13:20) - biospace.com/
NRSN | News | $2.5 47.06% 0.0% | twitter stocktwits trandingview |
| | O: -4.96% H: 8.96% C: 1.49%

drug als therapeutics
Voyager Therapeutics’ TRACER™ Capsids Demonstrate Enhanced CNS Transduction Across Species; New Preclinical Results Bolster GBA1, Tau, SOD1 ALS Gene Therapy Programs
Published: 2022-05-19 (Crawled : 12:00) - biospace.com/
VYGR P | $5.95 3.3% -5.56% | twitter stocktwits trandingview |
Health Technology
| | O: -1.86% H: 3.8% C: 0.95%

preclinical als therapy results pre-clinical
Neuvivo Begins Manufacturing of NP001 for Treatment of ALS
Published: 2022-05-11 (Crawled : 14:00) - biospace.com/
TMO | $543.64 -0.22% 0.05% | twitter stocktwits trandingview |
Health Technology
| | O: -0.88% H: 0.0% C: 0.0%

np001 treatment for als
Amylyx Augments Case for ALS Drug Ahead of PDUFA Date
Published: 2022-05-05 (Crawled : 22:00) - biospace.com/
CLNN | News P | $3.09 6.55% -13.79% | twitter stocktwits trandingview |
| | O: 0.0% H: 0.32% C: -7.96%

drug pdufa for als
Amylyx Pharmaceuticals Announces Publication of New CENTAUR Trial Analyses Further Demonstrating Significant Survival Benefit with AMX0035 in People with ALS
Published: 2022-05-05 (Crawled : 18:00) - biospace.com/
AMLX | $19.94 6.57% 4.97% | twitter stocktwits trandingview |
| | O: -0.79% H: 1.1% C: -7.57%

amx0035 als trial publication
Denali/Sanofi ALS Candidate Hits Phase II as Awareness Month Begins
Published: 2022-05-03 (Crawled : 15:00) - biospace.com/
SNY | News | $52.62 -1.5% -0.41% | twitter stocktwits trandingview |
Health Technology
| | O: 1.21% H: 0.0% C: 0.0%

als
Environmental Testing Market Size to Grow by USD 3.79 Billion | Alpha Analytical Inc., ALS Ltd., and American Environmental Testing Laboratory LLC Emerge as Dominant Players | Technavio
Published: 2022-05-03 (Crawled : 01:00) - prnewswire.com
IKTSY | News | $53.0 | twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 1.6% H: 1.26% C: 1.07%

als market test
Denali Therapeutics Announces Achievement of RIPK1 Milestone for Phase 2 Clinical Trial Initiation in ALS by Sanofi
Published: 2022-05-02 (Crawled : 13:00) - biospace.com/
SNY | News | $52.62 -1.5% -0.41% | twitter stocktwits trandingview |
Health Technology
| | O: -2.05% H: 0.0% C: 0.0%
DNLI D | $30.75 -0.58% 3.46% | twitter stocktwits trandingview |
Health Technology
| | O: -6.34% H: 6.77% C: 6.48%
SNYNF | News | $104.5 | twitter stocktwits trandingview |
Health Technology
| | O: 0.08% H: 0.0% C: 0.0%

for als trial therapeutics sanofi milestone
Wave Life Sciences Announces Publication of Foundational Preclinical Data Supporting Development of WVE-004 for C9orf72-associated ALS and FTD
Published: 2022-04-25 (Crawled : 13:00) - biospace.com/
WVE | $2.66 -5.67% -1.42% | twitter stocktwits trandingview |
Health Technology
| | O: 2.67% H: 7.81% C: 5.21%

wve-004 preclinical for als publication pre-clinical
NeuroSense Therapeutics Commences Enrollment and Dosing in its Pharmacokinetic Study of PrimeC for ALS
Published: 2022-04-11 (Crawled : 13:20) - biospace.com/
NRSN | News | $2.5 47.06% 0.0% | twitter stocktwits trandingview |
| | O: -2.12% H: 0.72% C: -13.72%

primec for als therapeutics enroll
NeuroSense Therapeutics Granted Patent in Canada for its ALS Drug PrimeC
Published: 2022-04-06 (Crawled : 14:00) - biospace.com/
NRSN | News | $2.5 47.06% 0.0% | twitter stocktwits trandingview |
| | O: 1.46% H: 1.28% C: -10.5%

drug patent primec canada als granted therapeutics grant
Spirit of ALS Patient Drives NeuroSense Mission to Bring PrimeC to Market
Published: 2022-03-31 (Crawled : 05:00) - biospace.com/
CLNN | News P | $3.09 6.55% -13.79% | twitter stocktwits trandingview |
| | O: 0.28% H: 14.44% C: 9.44%

primec als market
Your saved searches
Save your searches and get alerts when important news are released.

Mentioned Today
ABBV | News | $153.14 0.53% 0.04% | twitter stocktwits trandingview |
Health Technology

APPN | News 4 | $54.46 -1.05% 0.38% | twitter stocktwits trandingview |
Technology Services

APPS | News | $17.62 1.62% 5.48% | twitter stocktwits trandingview |
Technology Services

APYX | News | $6.04 1.51% 0.0% | twitter stocktwits trandingview |
Health Technology

BNPQF | News | $50.78 | twitter stocktwits trandingview |
Finance

BNPQY | News | $25.46 | twitter stocktwits trandingview |
Finance and Insurance

BNPZY | News | $ 0% | twitter stocktwits trandingview |
Finance and Insurance

CNXC | News | $147.67 1.63% -0.04% | twitter stocktwits trandingview |
Information

CNXCV | News | $2.27 0% | twitter stocktwits trandingview |
Commercial Services

DMYD | News | $16.21 0% | twitter stocktwits trandingview |
Finance

DMYT | News | $22.76 0% | twitter stocktwits trandingview |
Finance

DRE | News | $56.17 -2.23% 0.0% | twitter stocktwits trandingview |
Finance

EPZM | News | $1.47 54.09% 7.97% | twitter stocktwits trandingview |
Health Technology

ET | News | $10.14 0.4% 0.59% | twitter stocktwits trandingview |
Industrial Services

FBNC | News | $35.7 2.32% 0.0% | twitter stocktwits trandingview |
Finance

FBP | News | $13.52 0.67% 0.0% | twitter stocktwits trandingview |
Finance

FTRP | News | $0.81 1.25% 0.0% | twitter stocktwits trandingview |
Health Care and Social Assistan...

GRRB | News | $30.6 | twitter stocktwits trandingview |
Finance and Insurance

HR | News | $27.23 1.38% 0.0% | twitter stocktwits trandingview |
Finance

HTA | News | $27.7 -0.22% 0.0% | twitter stocktwits trandingview |
Finance

IE | News 0 d new | $ 0% | twitter stocktwits trandingview |
n/a

IONQ | News | $4.83 -5.48% 2.07% | twitter stocktwits trandingview |
Professional, Scientific, and T...

LLY | News 4 | $327.27 0.51% 0.04% | twitter stocktwits trandingview |
Health Technology

LMPX | News | $4.62 0.43% 0.0% | twitter stocktwits trandingview |
Technology Services

NFLX | News | $189.14 -0.9% 0.52% | twitter stocktwits trandingview |
Consumer Services

OBCI | News | $12.86 0.0% | twitter stocktwits trandingview |
Consumer Non-Durables

OMC | News | $64.75 0.23% 0.0% | twitter stocktwits trandingview |
Commercial Services

ONEW | News | $35.25 3.68% 0.0% | twitter stocktwits trandingview |
Retail Trade

OSCR | News | $4.55 2.94% 0.0% | twitter stocktwits trandingview |

PACB | News | $5.3 -5.53% -1.78% | twitter stocktwits trandingview |
Health Technology

PEGA | News | $51.68 -1.97% 0.0% | twitter stocktwits trandingview |
Technology Services

PFHC | News | $19.75 6.35% -4.95% | twitter stocktwits trandingview |

PLD | News | $120.21 -1.94% 0.54% | twitter stocktwits trandingview |
Finance

PSORF | News | $9.55 0% | twitter stocktwits trandingview |
Consumer Services

RDUS | News | $10.205 0.94% -0.4% | twitter stocktwits trandingview |
Health Technology

SNY | News | $52.62 -1.5% -0.41% | twitter stocktwits trandingview |
Health Technology

SNYNF | News | $104.5 | twitter stocktwits trandingview |
Health Technology

SPRO | News | $0.931 -0.96% 3.19% | twitter stocktwits trandingview |
Health Technology

SREV | News | $1.45 -2.76% | twitter stocktwits trandingview |
Technology Services

TGTX | News | $4.34 -1.36% -2.05% | twitter stocktwits trandingview |
Health Technology

TUP | News 4 | $7.16 1.42% 0.0% | twitter stocktwits trandingview |
Producer Manufacturing

USAK | News | $30.85 -0.48% -0.39% | twitter stocktwits trandingview |
Transportation

USWS | News | $0.995 4.08% -0.63% | twitter stocktwits trandingview |
Finance

VRCA | News | $2.195 4.03% 10.43% | twitter stocktwits trandingview |
Health Technology

WWE | News | $61.0 0.63% 0.0% | twitter stocktwits trandingview |
Consumer Services

XRAY | News | $36.74 -0.05% 0.0% | twitter stocktwits trandingview |
Health Technology

ZEN | News | $74.65 0.65% -0.07% | twitter stocktwits trandingview |
Technology Services